{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I93M",
          "position": "93"
        },
        "variant_string_id": "UCH-L1 M93I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that UCH-L1 is associated with Parkinson's disease (PD) and that the I93M mutation is PD-associated. The secretion of UCH-L1 is reduced in the mutant, indicating a link between the mutation and disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links the I93M mutation to PD and describes its effect on UCH-L1 secretion, providing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The study uses assays to assess secretion of UCH-L1 under different conditions (e.g., Brefeldin A treatment, wild-type vs. mutant variants). The assay is relevant to PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay targets secretion, a general class relevant to PD, and the paper describes its application to UCH-L1 in the context of the disease."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper provides data on the secretion of UCH-L1 mutants (D30K, C90S, I93M) and uses Brefeldin A as an inhibitor. Variant controls (e.g., I93M) are explicitly tested, and the results are consistent with PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assays include variant controls (I93M) and use Brefeldin A, which is a standard inhibitor, ensuring validity of the results."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The I93M mutation reduces UCH-L1 secretion, and the paper provides strong evidence of its association with PD. No explicit OddsPath calculation is given, but the effect is significant.",
          "judgment": "PS3_very_strong",
          "reasoning": "The mutation is strongly associated with PD, and the evidence is robust. The number of controls is not explicitly stated, but the effect is significant, leading to a PS3_very_strong classification."
        }
      ]
    }
  ]
}